Safety and effectiveness of iguratimod in patients with rheumatoid arthritis: Final report of a 52-week, multicenter postmarketing surveillance study

  • Tsuneyo Mimori, Masayoshi Harigai, Tatsuya Atsumi, Takao Fujii, Masataka Kuwana, Hiroaki Matsuno, Shigeki Momohara, Syuji Takei, Naoto Tamura, Yoshinari Takasaki, Kazuhiko Yamamoto, Satoshi Ikeuchi, Satoru Kushimoto, Takao Koike
  • Modern Rheumatology, April 2018, Taylor & Francis
  • DOI: 10.1080/14397595.2018.1460230

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/14397595.2018.1460230